Health Care Select Sector SPDR Fund
0
Funds holding %
of 7,425 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
22% more first-time investments, than exits
New positions opened: 214 | Existing positions closed: 176
0% more funds holding
Funds holding: 1,716 [Q3] → 1,722 (+6) [Q4]
6% less repeat investments, than reductions
Existing positions increased: 610 | Existing positions reduced: 651
1.82% less ownership
Funds ownership: 73.27% [Q3] → 71.45% (-1.82%) [Q4]
7% less capital invested
Capital invested by funds: $30.6B [Q3] → $28.3B (-$2.29B) [Q4]
27% less call options, than puts
Call options by funds: $1.92B | Put options by funds: $2.62B
27% less funds holding in top 10
Funds holding in top 10: 112 [Q3] → 82 (-30) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for XLV.
Financial journalist opinion
Based on 17 articles about XLV published over the past 30 days
Neutral
CNBC Television
3 hours ago
Final Trade: SBUX, META, XLV and BABA
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Negative
Zacks Investment Research
16 hours ago
Is Healthcare Losing the Status of Safe Haven? ETFs in Focus
Healthcare stocks face new risks under Trump, despite their usual defensive reputation.
Negative
Seeking Alpha
6 days ago
XLV Vs. VHT: I Prefer XLV For Its Better Downturn Resilience
The Healthcare Sector, represented by XLV and VHT ETFs, offers a defensive investment option amid current market volatility and potential recession risks. Between these two funds, I prefer XLV even better. XLV has shown better performance in past market downturns - compared to both VHT and SP500 - with smaller worst-year losses and also worse drawdowns.
Positive
Seeking Alpha
1 week ago
Two Stocks To Consider During Market Unrest To Provide Income Stability
Investors should remain calm amid market volatility and consider buying during price dips, with 2025 expected to see more turbulence. Kenvue's strong brand portfolio and solid liquidity offer price stability and a 3.59% dividend yield, despite potential headwinds from tariffs and economic slowdown. Altria Group, with its 7% yield and Dividend King status, provides stability and potential upside during economic uncertainty, leveraging its pricing power and recession-proof products.
Positive
Seeking Alpha
1 week ago
5 Dividend Growth Stocks I'm Buying As Defensive Sectors Become Sexy Again
The market has shifted from tech to defensive stocks, with real estate and consumer staples outperforming due to tariffs and trade wars. US companies with high foreign sales exposure are struggling, while non-US stocks benefit from an international backlash against US tariffs. My buy list is narrowing, focusing on undervalued, high-conviction dividend growth stocks like Blackstone and Alphabet, despite market volatility.
Negative
Bloomberg Markets and Finance
2 weeks ago
Trump Says Pharmaceutical Tariffs Coming in Near Future
President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum. Trump spoke with reporters Monday in the Oval Office.
Negative
Zacks Investment Research
2 weeks ago
5 Sector ETFs Set for Q1 Earnings Growth Amid Tariff Woes
We highlight ETFs from the sectors expected to post Q1 earnings growth that could make great plays amid tariff woes.
Negative
CNBC
2 weeks ago
Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages
President Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences on the drug supply chain, manufacturers and American patients, some experts told CNBC. The tariffs could disrupt the complex pharmaceutical supply chain, potentially driving up the prices of drugs in the U.S. and exacerbating shortages of critical medicine.
Neutral
Zacks Investment Research
2 weeks ago
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Health Care Select Sector SPDR ETF (XLV) is a passively managed exchange traded fund launched on 12/16/1998.
Negative
Reuters
3 weeks ago
Explainer: Prescription drugs become a target in Trump's trade war
U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that have long been spared from past trade disputes due to the potential for harm to patients.
Charts implemented using Lightweight Charts™